Course Overview
The Advanced Weight Management Certification: GLP-1 Agonists (Semaglutide) and Emerging Therapies by Empire Medical Training is designed for licensed healthcare professionals—including physicians, nurse practitioners, physician assistants, and nurses—who aim to integrate evidence-based weight loss solutions into their practice. This comprehensive program covers the latest advancements in weight management, focusing on FDA-approved pharmaceutical treatments such as GLP-1 receptor agonists (e.g., semaglutide), hormonal protocols, and adjunctive therapies. Participants will engage in detailed instruction on patient assessment, personalized treatment planning, and the implementation of effective weight loss strategies. All necessary course materials are included in the tuition. Continuing Medical Education (CME) credits are available upon completion. There are no prerequisites.
What to Expect
- Understand the mechanisms and protocols for GLP-1 receptor agonists like semaglutide and tirzepatide to support effective weight management.
- Evaluate and treat hormonal imbalances contributing to obesity using evidence-based weight loss protocols.
- Use adjunctive therapies such as MIC injections, Vitamin B-12, and supplements to enhance patient results.
- Perform comprehensive patient assessments, including lab workups, to design personalized weight loss plans.
- Integrate medical weight loss services into your practice with strategies for implementation, marketing, and revenue growth.
.png)
.webp)